首页> 外文OA文献 >Phase II randomized trial of a non-steroidal mouth wash for prevention and treatment of stomatitis in women with hormone receptor positive breast cancer treated with everolimus

【2h】

Phase II randomized trial of a non-steroidal mouth wash for prevention and treatment of stomatitis in women with hormone receptor positive breast cancer treated with everolimus

机译：非甾体口洗涤的II期随机试验，用于预防和治疗血管素受体阳性乳腺癌患者口腔炎的预防和治疗

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
引文网络
相似文献
相关主题

著录项

作者
Parvin F. Peddi; Merry Tetef; Paul Coluzzi; Karo K. Arzoo; Eddie H. Hu; Maurice J. Berkowitz; David Chan; Dennis Moore; Brad Adams; Xiaoyan Wang; Sara A. Hurvitz;
展开▼
作者单位

展开▼
年度 2020
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
中文文献
专利

1. 5027 A randomized, phase III trial exploring the effects of neoadjuvant sequential treatment with steroidal (exemestane) and non-steroidal (anastrozole) aromatase inhibitors on biomarkers in post-menopausal women with hormone receptor positive locally advanced breast cancer (LABC) [J] . O.Freedman, E.Amir, G.Dranitsaris, European Journal of Cancer Supplements . 2009,第2期

机译：5027一项随机的，III期临床试验，探讨了甾体（依西美坦）和非甾体（阿那曲唑）芳香化酶抑制剂新辅助序贯治疗对绝经后激素受体阳性局部晚期乳腺癌（LABC）妇女的生物标志物的影响
2. Prevention of everolimus-related stomatitis in women with hormone receptor-positive, HER2-negative metastatic breast cancer using dexamethasone mouthwash (SWISH): a single-arm, phase 2 trial [J] . Rugo Hope S., Seneviratne Lasika, Beck J. Thaddeus, The lancet oncology . 2017,第5期

机译：使用邻塞米松漱口水（浅频道）预防激素受体阳性，HER2阴性转移性乳腺癌的妇女对血管血症相关的口腔炎：单臂，第2期试验
3. Randomized Phase II Trial of Fulvestrant Plus Everolimus or Placebo in Postmenopausal Women With Hormone Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative Metastatic Breast Cancer Resistant to Aromatase Inhibitor Therapy: Results of PrE0102 [J] . Kornblum Noah, Zhao Fengmin, Manola Judith, Journal of Clinical Oncology . 2018,第16期

机译：随机二期试验氟斯特语加血管血清或安慰剂在绝经后妇女患有激素受体阳性，人表皮生长因子受体2阴性转移性乳腺癌抗性芳香酶抑制剂治疗：pre0102的结果
4. Results of treatment in patients with IIa - IIIast. breast cancer treated by combination of low-level laser therapy (LLLT) and surgery (5-year experience) [C] . V.A. Mikhailov, Ctr. of Laser Medicine, Moscow, CIS Selected Papers: Laser Use in Oncology . 1996

机译：IIa-IIIast患者的治疗结果。低水平激光疗法（LLLT）和手术相结合治疗乳腺癌（5年经验）
5. Treatment Interruption and Discontinuation of Hormone Therapy in Hormone Receptor-Positive Breast Cancer Patients [D] . Mao, Daqin . 2020

机译：激素受体阳性乳腺癌患者中的治疗中断与激素治疗中的中断和停止
6. Phase II randomized trial of a non-steroidal mouth wash forprevention and treatment of stomatitis in women with hormone receptor positivebreast cancer treated with everolimus [O] . Parvin F. Peddi, Merry Tetef, Paul Coluzzi, 2020

机译：II期无甾体口洗涤的随机试验激素受体阳性女性口腔炎的预防和治疗乳腺癌用everolimus治疗
7. Efficacy and safety of everolimus plus exemestane in postmenopausal women with hormone receptor-positive, human epidermal growth factor receptor 2-negative locally advanced or metastatic breast cancer: Results of the single-arm, phase IIIB 4EVER trial [O] . Hans Tesch, Oliver Stoetzer, Thomas Decker, 2018

机译：Everolimus Plus Exemestan在绝经后妇女患有激素受体阳性，人表皮生长因子受体2阴性局部晚期或转移性乳腺癌的疗效和安全性：单臂，IIIB的结果结果

Phase II randomized trial of a non-steroidal mouth wash for prevention and treatment of stomatitis in women with hormone receptor positive breast cancer treated with everolimus

著录项

引文网络

相似文献

相关主题

期刊订阅